The prothrombin gene G20210A variant and puerperal cerebral venous and sinus thrombosis in South Indian women

Journal of Clinical Neuroscience

Volumn 14, Issue 7, 2007, Pages 635-638

  Nagaraja, Dindagur ^a   Kruthika Vinod, T P ^a   Christopher, Rita ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Prothrombin G20210A polymorphism; Puerperal cerebral veno sinus thrombosis

Indexed keywords

G20210A PROTEIN; GENE PRODUCT; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; VEIN THROMBOSIS;

ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INDIA; POLYMORPHISM, GENETIC; PROTHROMBIN; PUERPERAL DISORDERS; SINUS THROMBOSIS, INTRACRANIAL; VENOUS THROMBOSIS;

EID: 34249045125     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.05.001     Document Type: Article

References (29)

1. Greer I.A. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 342 (2000) 424-425
2. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium. A study of 135 patients. Angiology 34 (1983) 731-746
3. Vicente V., Gonzalez-Conejero R., Rivera J., et al. The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica 84 (1999) 356-362
4. Rosendaal F.R., Doggen C.J., and Zivelin A. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79 (1998) 706-708
5. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16 (1988) 1215
6. Poort S.R., Rosendaal F.R., Reitsma P.H., et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
7. Nagaraja D., and Sarma G.R. Treatment of cerebral sinus/venous thrombosis. Neurol India 50 (2002) 114-116
8. Degan S.J.F., and Davie E.W. Nucleotide sequence of the gene for human prothrombin. Biochemistry 26 (1987) 6165
9. Gehring N.H., Frede U., Neu-Yilik G., et al. Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 28 (2001) 389-392
10. Tripodi A., Chantarangkul V., Mannucci P.M., et al. Hyperprothrombinemia may result in acquired activated protein C resistance. Blood 96 (2000) 3295-3296
11. Cumming A.M., Keeney S., Salden A., et al. The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. Br J Haematol 98 (1997) 353-355
12. Dilley A., Austin H., Hooper W.C., et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 132 (1998) 452-455
13. Isshiki I., Murata M., Watanabe R., et al. Frequencies of prothrombin 20210 G → A mutation may be different among races-studies on Japanese populations with various forms of thrombotic disorders and healthy subjects. Blood Coagul Fibrinolysis 9 (1998) 105-106
14. Hillarp A., Zoller B., Svensson P.J., et al. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 78 (1997) 990-992
15. Young G., Manco-Johnson M., Gill J.C., et al. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost 1 (2003) 958-962
16. Hillier C.E., Collins P.W., Bowen D.J., et al. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 91 (1998) 677-680
17. Madonna P., de Stefano A., Coppola A., et al. G20210A PRTH gene mutation and other thrombophilic polymorphisms in cerebral venous thrombosis. Stroke 31 (2000) 1787-1788
18. Martinelli I., Sacchi E., Landi G., et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives. N Engl J Med 338 (1998) 1793-1797
19. Reuner K.H., Ruf A., Grau A., et al. Prothrombin gene G20210-A transition is a risk factor for cerebral venous thrombosis. Stroke 29 (1998) 1765-1769
20. Rodrigues C.A., Rocha L.K., Morelli V.M., et al. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost 2 (2004) 1211-1212
21. Gadelha T., Andre C., Juca A.A., et al. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis 19 (2005) 49-52
22. Lichy C., Dong-Si T., Reuner K., et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol 253 (2006) 16-20
23. Dentali F., Crowther M., and Dentali W.A. Thrombophilic abnormalities, oral contraceptives and risk of cerebral vein thrombosis: a meta-analysis. Blood 107 (2006) 2766-2773
24. Weih M., Mehraein S., Valdueza J.M., et al. Coincidence of factor V Leiden mutation and a mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis. Stroke 29 (1998) 1739-1740
25. Garewal G., Das R., Ahluwalia J., et al. Prothrombin 20210A is not prevalent in North India. J Thromb Haemost 1 (2003) 2253-2254
26. Ghosh K., Shetty S., Madkaikar M., et al. Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 7 (2001) 158-165
27. Koshy A., and Jeyakumari M. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Ann Hematol 85 (2006) 126-128
28. Angeline T., Bentley H.A., Hawk A.B., et al. Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol 79 (2005) 9-13
29. Rees D.C., Chapman N.H., Webster M.T., et al. Born to clot: the European burden. Br J Haematol 105 (1999) 564-566